Early-Career Members Join NMD4C Working Groups
The NMD4C is happy to announce that six early-career network members have been appointed to leadership roles on three NMD4C working groups: Biobanking, Early-Career, and Knowledge Translation.
The network looks forward to the valuable input and broadened perspective that each member has or will provide to these network activities, and would like to welcome the following early-career members to our working groups:
- Drs. Élise Duchesne and Gerald Pfeffer, who have joined the biobanking working group.
- Drs. Natasha Chang and Cam-Tu Nguyen, who have joined the Early-Career working group.
- Drs. Kessen Patten and Mona Hnaini, who have joined the Knowledge Translation working group.
The NMD4C are committed to empowering the next generation of early-career researchers and clinicians in building successful careers in neuromuscular disease research and clinical practice. Providing early-career leadership opportunities within the network will not only amplify the early-career perspective and help to inform the network’s activities, but also empowers our members to become future leaders in the neuromuscular community.
Other opportunities that the NMD4C provides for early-career members include:
- Sharing blog posts from early-career members
- Research and clinical fellowship funding opportunities
- Webinars and events tailored to early-career audience
If you are an early-career researcher or clinician, please feel free to visit our early-career page or contact James Davis at if you are interested in further engagement with the network.
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.